Vertex Pharmaceuticals Inc. buy UBS Group AG
Start price
09.12.25
/
50%
€379.15
Target price
09.12.26
-
Performance (%)
0.69%
Price
09:59
€381.75
Summary
This prediction is currently active. Since the start of the prediction for Vertex Pharmaceuticals Inc. the price has only changed by 0.69%. This prediction currently runs until 09.12.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Vertex Pharmaceuticals Inc. | 0.763% |
| iShares Core DAX® | -1.212% |
| iShares Nasdaq 100 | -4.714% |
| iShares Nikkei 225® | -2.976% |
| iShares S&P 500 | -2.744% |
Comments by UBS_Group_AG for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€352.60
07.11.25
07.11.25
€473.22
07.11.26
07.11.26
8.27%
09:59
09:59
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€344.35
05.08.25
05.08.25
€478.40
05.08.26
05.08.26
10.86%
09:59
09:59
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€459.85
05.11.24
05.11.24
€536.01
05.11.25
05.11.25
-21.69%
06.11.25
06.11.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€459.95
17.10.24
17.10.24
€519.06
17.10.25
17.10.25
-21.84%
18.10.25
18.10.25